August 6, 2026 Phase 1 Trial Shows Safety and Clinical Benefit of CAR-T Cell Therapy for Glioblastoma
July 31, 2026 PRISM2: Multimodal Foundation Model Achieves Clinical-Grade Cancer Detection in Computational Pathology
